Lori Gardi

Robarts Clinical Trials

Papers

9

Total Citations

291

H-Index

6

About

Lori Gardi is a leading researcher in medical robotics and image-guided therapy, with a primary focus on advancing brachytherapy for prostate and breast cancers. Her work centers on integrating 3D transrectal ultrasound (TRUS) guidance with robotic systems to overcome critical clinical challenges, such as pubic arch interference during prostate seed implantation. Gardi’s seminal 2004 paper on robot-assisted 3D-TRUS guided prostate brachytherapy (186 citations) established a foundational framework for intraoperative, dynamic dose re-optimization by enabling oblique needle trajectories—a major departure from traditional parallel insertions. She further developed algorithms for oblique needle segmentation and tracking in 3D TRUS images, enhancing real-time procedural accuracy. Her innovations extend to breast cancer treatment, where she pioneered a novel robot-assisted 3D ultrasound system for real-time planning and guidance of interstitial high-dose-rate brachytherapy, and explored the use of 3D printing for personalized treatment. With over 290 cumulative citations, Gardi’s contributions have directly improved the precision, adaptability, and patient outcomes of minimally invasive cancer therapies, establishing her as a key figure in the evolution of image-guided robotic interventions.

Research Focus

Key Achievements

6
H-Index
9
Papers
291
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted 3D-TRUS guided prostate brachytherapy: System integration and validation
186 citations · 2004
📈 Most Prolific Year: 2004 (3 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Robarts Clinical Trials

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago